A citation-based method for searching scientific literature

Jingquan Li, Mian Li, Peizhan Chen, Qian Ba. FEBS Open Bio 2017
Times Cited: 12







List of co-cited articles
27 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The Role of PALB2 in the DNA Damage Response and Cancer Predisposition.
Thales C Nepomuceno, Giuliana De Gregoriis, Francisco M Bastos de Oliveira, Guilherme Suarez-Kurtz, Alvaro N Monteiro, Marcelo A Carvalho. Int J Mol Sci 2017
51
50

Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer.
Silvia Casadei, Barbara M Norquist, Tom Walsh, Sunday Stray, Jessica B Mandell, Ming K Lee, John A Stamatoyannopoulos, Mary-Claire King. Cancer Res 2011
174
33

Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
Fergus J Couch, Hermela Shimelis, Chunling Hu, Steven N Hart, Eric C Polley, Jie Na, Emily Hallberg, Raymond Moore, Abigail Thomas, Jenna Lilyquist,[...]. JAMA Oncol 2017
347
25

PALB2 is an integral component of the BRCA complex required for homologous recombination repair.
Shirley M H Sy, Michael S Y Huen, Junjie Chen. Proc Natl Acad Sci U S A 2009
384
25

Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer.
Christian Bowman-Colin, Bing Xia, Samuel Bunting, Christiaan Klijn, Rinske Drost, Peter Bouwman, Laura Fineman, Xixi Chen, Aedin C Culhane, Hong Cai,[...]. Proc Natl Acad Sci U S A 2013
40
25

Breast-cancer risk in families with mutations in PALB2.
Antonis C Antoniou, Silvia Casadei, Tuomas Heikkinen, Daniel Barrowdale, Katri Pylkäs, Jonathan Roberts, Andrew Lee, Deepak Subramanian, Kim De Leeneer, Florentia Fostira,[...]. N Engl J Med 2014
520
25

Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.
Bing Xia, Qing Sheng, Koji Nakanishi, Akihiro Ohashi, Jianmin Wu, Nicole Christ, Xinggang Liu, Maria Jasin, Fergus J Couch, David M Livingston. Mol Cell 2006
579
25

PALB2 mutations in familial breast and pancreatic cancer.
Erin W Hofstatter, Susan M Domchek, Alexander Miron, Judy Garber, Molin Wang, Kathryn Componeschi, Leigh Boghossian, Penelope L Miron, Katherine L Nathanson, Nadine Tung. Fam Cancer 2011
81
25

The Tumor Suppressor PALB2: Inside Out.
Mandy Ducy, Laura Sesma-Sanz, Laure Guitton-Sert, Anahita Lashgari, Yuandi Gao, Nadine Brahiti, Amélie Rodrigue, Guillaume Margaillan, Marie-Christine Caron, Jacques Côté,[...]. Trends Biochem Sci 2019
69
25

Association of PALB2 Messenger RNA Expression with Platinum-Docetaxel Efficacy in Advanced Non-Small Cell Lung Cancer.
Niki Karachaliou, Jillian Wilhelmina Paulina Bracht, Manuel Fernandez Bruno, Ana Drozdowskyj, Ana Gimenez Capitan, Teresa Moran, Enric Carcereny, Manuel Cobo, Manuel Domine, Imane Chaib,[...]. J Thorac Oncol 2019
8
37

The spectrum of genetic mutations in breast cancer.
Asfandyar Sheikh, Syed Ather Hussain, Quratulain Ghori, Nida Naeem, Abul Fazil, Smith Giri, Brijesh Sathian, Prajeena Mainali, Dalal M Al Tamimi. Asian Pac J Cancer Prev 2015
39
16

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.
Melissa C Southey, David E Goldgar, Robert Winqvist, Katri Pylkäs, Fergus Couch, Marc Tischkowitz, William D Foulkes, Joe Dennis, Kyriaki Michailidou, Elizabeth J van Rensburg,[...]. J Med Genet 2016
124
16

PALB2: research reaching to clinical outcomes for women with breast cancer.
Melissa C Southey, Ingrid Winship, Tú Nguyen-Dumont. Hered Cancer Clin Pract 2016
18
16

Association of common PALB2 polymorphisms with breast cancer risk: a case-control study.
Peizhan Chen, Jie Liang, Zhanwei Wang, Xiaoyi Zhou, Lu Chen, Mian Li, Dong Xie, Zhibin Hu, Hongbing Shen, Hui Wang. Clin Cancer Res 2008
36
16

Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.
Bing Xia, Josephine C Dorsman, Najim Ameziane, Yne de Vries, Martin A Rooimans, Qing Sheng, Gerard Pals, Abdellatif Errami, Eliane Gluckman, Julian Llera,[...]. Nat Genet 2007
345
16

Penetrance analysis of the PALB2 c.1592delT founder mutation.
Hannele Erkko, James G Dowty, Jenni Nikkilä, Kirsi Syrjäkoski, Arto Mannermaa, Katri Pylkäs, Melissa C Southey, Kaija Holli, Anne Kallioniemi, Arja Jukkola-Vuorinen,[...]. Clin Cancer Res 2008
77
16

Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma.
Koji Shindo, Jun Yu, Masaya Suenaga, Shahriar Fesharakizadeh, Christy Cho, Anne Macgregor-Das, Abdulrehman Siddiqui, P Dane Witmer, Koji Tamura, Tae Jun Song,[...]. J Clin Oncol 2017
233
16

PALB2 mutations in European familial pancreatic cancer families.
E P Slater, P Langer, E Niemczyk, K Strauch, J Butler, N Habbe, J P Neoptolemos, W Greenhalf, D K Bartsch. Clin Genet 2010
173
16

Routine testing for PALB2 mutations in familial pancreatic cancer families and breast cancer families with pancreatic cancer is not indicated.
Femme Harinck, Irma Kluijt, Saskia E van Mil, Quinten Waisfisz, Theo A M van Os, Cora M Aalfs, Anja Wagner, Maran Olderode-Berends, Rolf H Sijmons, Ernst J Kuipers,[...]. Eur J Hum Genet 2012
31
16

PALB2 links BRCA1 and BRCA2 in the DNA-damage response.
Feng Zhang, Jianglin Ma, Jiaxue Wu, Lin Ye, Hong Cai, Bing Xia, Xiaochun Yu. Curr Biol 2009
354
16

PALB2 and breast cancer: ready for clinical translation!
Melissa C Southey, Zhi L Teo, Ingrid Winship. Appl Clin Genet 2013
32
16


PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.
Nazneen Rahman, Sheila Seal, Deborah Thompson, Patrick Kelly, Anthony Renwick, Anna Elliott, Sarah Reid, Katarina Spanova, Rita Barfoot, Tasnim Chagtai,[...]. Nat Genet 2007
677
16

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.
Jianjiong Gao, Bülent Arman Aksoy, Ugur Dogrusoz, Gideon Dresdner, Benjamin Gross, S Onur Sumer, Yichao Sun, Anders Jacobsen, Rileen Sinha, Erik Larsson,[...]. Sci Signal 2013
16

Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene.
Siân Jones, Ralph H Hruban, Mihoko Kamiyama, Michael Borges, Xiaosong Zhang, D Williams Parsons, Jimmy Cheng-Ho Lin, Emily Palmisano, Kieran Brune, Elizabeth M Jaffee,[...]. Science 2009
558
16

Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer.
Sarah Reid, Detlev Schindler, Helmut Hanenberg, Karen Barker, Sandra Hanks, Reinhard Kalb, Kornelia Neveling, Patrick Kelly, Sheila Seal, Marcel Freund,[...]. Nat Genet 2007
446
16

Development and validation of molecular methodologies to assess PALB2 expression in sporadic breast cancer.
Nikoleta Poumpouridou, Amelia Acha-Sagredo, Nikolaos Goutas, Dimitrios Vlachodimitropoulos, Ioanna Chatziioannidou, Evi Lianidou, Triantafyllos Liloglou, Christos Kroupis. Clin Biochem 2016
4
50

Role of CCL20/CCR6 and the ERK signaling pathway in lung adenocarcinoma.
Xiao-Peng Zhang, Zhi-Juan Hu, Ai-Hong Meng, Guo-Chen Duan, Qing-Tao Zhao, Jing Yang. Oncol Lett 2017
25
8

Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors.
Viktor A Adalsteinsson, Gavin Ha, Samuel S Freeman, Atish D Choudhury, Daniel G Stover, Heather A Parsons, Gregory Gydush, Sarah C Reed, Denisse Rotem, Justin Rhoades,[...]. Nat Commun 2017
348
8


Two faces of TGF-beta1 in breast cancer.
Joanna Magdalena Zarzynska. Mediators Inflamm 2014
155
8


The Changing Landscape of Genetic Testing for Inherited Breast Cancer Predisposition.
Anosheh Afghahi, Allison W Kurian. Curr Treat Options Oncol 2017
20
8

IL-32 promotes breast cancer cell growth and invasiveness.
Shouman Wang, Feiyu Chen, Lili Tang. Oncol Lett 2015
24
8

Can free DNA be detected in sputum of lung cancer patients?
M A van der Drift, C F M Prinsen, B E A Hol, A S Bolijn, M A F Jeunink, P N R Dekhuijzen, F B J M Thunnissen. Lung Cancer 2008
31
8


Production of CCL20 from lung cancer cells induces the cell migration and proliferation through PI3K pathway.
Beibei Wang, Lin Shi, Xiaoru Sun, Lingyan Wang, Xiangdong Wang, Chengshui Chen. J Cell Mol Med 2016
56
8

Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer.
Haeyoung Kim, Dae-Yeon Cho, Doo Ho Choi, Mijin Oh, Inkyung Shin, Won Park, Seung Jae Huh, Seok Jin Nam, Jeong Eon Lee, Seok Won Kim. Breast Cancer Res Treat 2017
19
8

Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.
Rossella Graffeo, Luca Livraghi, Olivia Pagani, Aron Goldhirsch, Ann H Partridge, Judy E Garber. Breast Cancer Res Treat 2016
39
8


Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients.
R J Wallace, B A Brown, D E Griffith, W M Girard, D T Murphy. Am J Respir Crit Care Med 1996
193
8

Challenges in Interpreting Germline Mutations in BARD1 and ATM in Breast and Ovarian Cancer Patients.
Kimberly DeLeonardis, Kristin Sedgwick, Olga Voznesensky, Ellen Matloff, Erin Hofstatter, Steven Balk, Nadine Tung. Breast J 2017
5
20

Interleukin 32, inflammation and cancer.
Jin Tae Hong, Dong Ju Son, Chong Kil Lee, Do-Young Yoon, Dong Hun Lee, Mi Hee Park. Pharmacol Ther 2017
83
8

Detection of novel germline mutations for breast cancer in non-BRCA1/2 families.
Fatima Aloraifi, Trudi McDevitt, Rui Martiniano, Jonah McGreevy, Russell McLaughlin, Chris M Egan, Nuala Cody, Marie Meany, Elaine Kenny, Andrew J Green,[...]. FEBS J 2015
33
8

ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast.
Zheng Ping, Gene P Siegal, Shuko Harada, Isam-Eldin Eltoum, Mariam Youssef, Tiansheng Shen, Jianbo He, Yingjie Huang, Dongquan Chen, Yiping Li,[...]. Oncotarget 2016
29
8

Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease.
R J Wallace, B A Brown, D E Griffith, W M Girard, D T Murphy, G O Onyi, V A Steingrube, G H Mazurek. Am J Respir Crit Care Med 1994
145
8

A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3.
Pablo Cingolani, Adrian Platts, Le Lily Wang, Melissa Coon, Tung Nguyen, Luan Wang, Susan J Land, Xiangyi Lu, Douglas M Ruden. Fly (Austin) 2012
8

The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer.
Martin Widschwendter, Michal Zikan, Benjamin Wahl, Harri Lempiäinen, Tobias Paprotka, Iona Evans, Allison Jones, Shohreh Ghazali, Daniel Reisel, Johannes Eichner,[...]. Genome Med 2017
81
8

Bronchiectasis and nontuberculous mycobacterial disease.
David E Griffith, Timothy R Aksamit. Clin Chest Med 2012
45
8

Amplicon-based next-generation sequencing of plasma cell-free DNA for detection of driver and resistance mutations in advanced non-small cell lung cancer.
N Guibert, Y Hu, N Feeney, Y Kuang, V Plagnol, G Jones, K Howarth, J F Beeler, C P Paweletz, G R Oxnard. Ann Oncol 2018
90
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.